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In order to obtain satisfactory column permeability, efficiency and selectivity for 41
micro-HPLC, a capillary monolithic column containing 42
O-9-[2-(methacryloyloxy)-ethylcarbamoyl]-10,11-dihydroquinidine (MQD) as chiral 43
selector was re-optimized. The monolithic column was used to successfully 44
enantioresolve a wide range of N-derivatized amino acids including alanine, leucine, 45
methionine, threonine, phenylalanine, valine, serine, isoleucine, tryptophan, and 46
cysteine. The influence of mobile phase parameters, such as the organic solvent type47
and concentration, the apparent pH, and buffer concentration, on retention and 48
enantioseparation of N-derivatized amino acids has been investigated.49
3,5-dinitrobenzoyl-amino acids and 3,5-dichlorobenzoyl-amino acids were resolved 50
into enantiomers with exceptionally high selectivity and resolution. The 51
chemoselectivity of the monolithic column for a multicomponent mixture of 52
N-derivatized amino acids was also investigated. A mixture of three pairs of53
3,5-dichlorobenzoyl-amino acids could be fully resolved in 22.5 minutes. 54
55
56
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The stereochemistry of amino acids plays an important role in their biological and 60
pharmacological properties. An increasing number of observations suggests that61
D-amino acids have a significant influence in living organisms, including humans [1]. 62
Some D-amino acids have been found to be related to different diseases, including63
schizophrenia [2], Alzheimer’s disease [3] and renal disorders [4]. For example, 64
D-serine may be useful as a biomarker and even a therapeutic agent for neurological 65
disorders [5], while L-serine plays a key role in the central nervous system and cellular 66
proliferation [6]. Moreover, amino acids as chiral building blocks have a significant 67
importance for synthetic therapeutic peptides [7]. However, it is difficult to resolve68
free amino acids into their enantiomers because of an obvious lack of appropriate 69
functionalities to interact with the chiral selectors [8]. In order to enhance the 70
intermolecular interaction between amino acids and chiral selectors, additional 71
interaction sites could be introduced through the derivatization of amino groups [9], 72
using reagents such as carbazole-9-carbonyl (CC) chloride [9], 2,4-dinitrophenyl 73
(DNP) fluoride [10], 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) [11], or dansyl 74
(DNS) chloride [12]. These UV-absorbing or fluorescent derivatization agents could 75
also bring a strong chromophore or fluorophore into amino acids and peptides for 76
improving detection sensitivity [9,13]. Therefore, the enantioseparation of 77
N-derivatized amino acids remains a hot research topic even if well advanced. A series 78
of chiral stationary phases (CSPs), containing polysaccharides [14], macrocyclic 79
antibiotics [15], native or cationic cyclodextrins (CD) [16], and 80
(S)-N-3,5-dinitrobenzoyl-1-naphthylglycine [17] as chiral selectors, have been applied 81
to the enantioseparation of different kinds of N-derivatized amino acids. In particular, 82
carbamoylated quinine and quinidine immobilized on silica microparticles have 83
received great attention due to their excellent enantioselectivity towards various kinds 84
of acidic analytes, such as N-derivatized amino acids [18-19], profens [20], -aryloxy 85
alkanoic acids [18], 1,4-dihydropyridine monocarboxylic acid [21], pyrethroic acids 86
[22], N-derivatized peptides [23], dafachronic acids [24], and aminophosphonic acids 87
[25]. The enantioselectivity could be attributed to a global effect, including ion-pair 88
formation between chiral analytes and selector, dipole-dipole, hydrophobic, hydrogen 89
bonding, π-π and steric interactions [26]. 90
In the last decade, monolithic columns have proved to be an effective alternative to91












packed columns and have attracted considerable interest owing to their facile 92
preparation methodology and good column characteristics, such as permeability and93
efficiency [27]. Lämmerhofer et al. developed quinine and quinidine-based chiral 94





yl methacrylate-co-ethylene dimethacrylate) (poly(MQD-co-HEMA-co-EDMA)) for 100
capillary electrochromatography (CEC) applications by in situ copolymerization of 101
O-9-(tert-butylcarbamoyl)-11-[2-(methacryloyloxy)ethylthio]-10,11-dihydroquinine 102
or O-9-[2-(methacryloyloxy)-ethylcarbamoyl]- 10,11-dihydroquinidine [12,28]. These 103
macroporous chiral monolithic columns exhibited very good enantioselectivity and 104
column efficiency in the CEC mode for several N-derivatized amino acids, such as 105
CC-Alanine, CC-Serine, and 3,5-dinitrobenzoyl (DNB)-Leucine [12,28-30]. However, 106
their applicability to micro-HPLC separations does not seem to have been 107
investigated so far. It is well known that the column properties required for 108
micro-HPLC are different from those for CEC. Therefore, a systematic optimization 109
of the polymerization conditions is required in order to obtain satisfactory 110
micro-HPLC performance with respect to column permeability, mechanical stability, 111
efficiency and selectivity. Besides, it is of high interest to systematically evaluate the 112
enantioselectivity of poly(MQD-co-HEMA-co-EDMA) monolithic columns towards a 113
wider range of analytes since only a few derivatives of leucine and valine have been 114
examined so far [12,28-30].115
In this study, a capillary liquid chromatography column containing carbamoylated 116
quinidine was prepared according to Lämmerhofer et al [28]. In order to obtain 117
satisfactory column permeability, efficiency and selectivity in micro-HPLC, the 118
composition of the polymerization mixture was re-optimized. The optimized 119
monolithic column was subsequently applied to the enantioseparation of various kinds 120
of N-derivatized amino acids, containing benzoyl (B), p-nitrobenzoyl (p-NB), 121
3,5-dinitrobenzoyl (3,5-DNB), 3,5-dimethoxybenzoyl (3,5-DMB), 122
9-fluorenylmethoxycarbonyl (Fmoc), 3,5-dichlorobenzoyl (3,5-DClB), 123
m-chlorobenzoyl (m-ClB), p-chlorobenzoyl (p-ClB), or o-chlorobenzoyl (o-ClB) 124
protecting groups. The influence of the organic solvent type and content, the buffer125












concentration and the apparent pH of the mobile phase on the enantioseparation of 126
these amino acid derivatives has also been investigated. The separation mechanism is127
also discussed on the basis of a comparison of the influence of the type of 128
N-protecting group and amino acid on enantioseparation.129
130
2. Experimental131
2.1. Chemicals and materials 132
3-(Trimethoxysilyl)-propyl methacrylate (-MAPS), 2,2'-azobisisobutyronitrile 133
(AIBN), 2-hydroxyethyl methacrylate (HEMA), ethylene dimethacrylate (EDMA), 134
methanol (MeOH), dodecanol, chloroform, cyclohexanol, acetonitrile (ACN), acetic 135
acid, ammonium formate , ammonium acetate and dibutyltin dilaurate were all 136
purchased from Aladdin Chemicals (Shanghai, China). 4-Methoxyphenol and 137
2-isocyanatoethyl methacrylate were obtained from Maya Reagent (Jiaxing, Zhejiang, 138
China). All racemic amino acids (alanine, leucine, methionine, threonine, 139
phenylalanine, valine, serine, isoleucine, tryptophan, and cysteine), 140
10,11-dihydroquinidine (DHQD) and nine aroyl chlorides (p-nitrobenzoyl chloride, 141
3,5-dinitrobenzoyl chloride, 3,5-dimethoxybenzoyl chloride, 142
9-fluorenylmethoxycarbonyl chloride, 3,5-dichlorobenzoyl chloride, m-chlorobenzoyl 143
chloride, p-chlorobenzoyl chloride, benzoyl chloride, and o-chlorobenzoyl chloride) 144
were purchased from Energy Chemical (Shanghai, China). All N-derivatized amino 145
acids were synthesized according to a standard procedure [31] except Fmoc and 146
3,5-DClB derivatives. As described previously [32], amino acids were amidated by 147
9-fluorenylmethoxycarbonyl chloride in aqueous solution to afford Fmoc-derivatized 148
amino acids. 3,5-DClB derivatives were synthesized through reaction of amino acids 149
with 3,5-dichlorobenzoyl chloride in THF [33]. Distilled water was filtered through a 150
2-μm membrane before use. The fused-silica capillaries (375 μm O.D. × 100 μm I.D.) 151
were obtained from Ruifeng Chromatography Ltd. (Yongnian, Hebei, China).152
153
2.2. Instrumentation154
All scanning electron microscopy (SEM) experiments were carried out using an 155
ultra-high 165 resolution Hitachi S-4800 SEM (Tokyo, Japan) at an acceleration 156
voltage of 1 kV. A Jinghong DK-S22 water bath (Shanghai, China) was used for 157
thermally initiated copolymerization. All micro-HPLC experiments were carried out 158












on a self-assembled HPLC system that consisted of a DiNa nano gradient pump 159
(Tokyo, Japan), a Valco four-port injection valve with 20 nL internal loop (Houston, 160
TX, USA), and a Shimadzu SPD-15C UV detector (Kyoto, Japan). Data acquisition 161
and data handling were performed using a Unimicro TrisepTM Workstation 2003 162
(Shanghai, China). All chromatograms were converted to a text file and redrawn using 163




Unless otherwise stated, the mobile phase was a mixture of ACN/0.1 M ammonium 168
acetate (80/20; v/v). The mobile phase apparent pH was adjusted to the desired value 169
by adding acetic acid. All chiral samples were dissolved in MeOH to reach a final 170
concentration around 1 mg/mL. The mobile phase was filtered through a 0.22-μm 171
membrane and degassed before use. The flow rate of the mobile phase was set at 1 172
μL/min and the injection volume was 20 nL. The analytes were all detected at a 173
wavelength of 254 nm. 174
175
2.4. Preparation of poly(MQD-co-HEMA-co-EDMA) monolithic columns176
2.4.1. Synthesis of 177
O-[2-(Methacryloyloxy)ethylcarbamoyl]-10,11-dihydroquinidine178
The functional monomer MQD was synthesized according to Lämmerhofer et al.  179
[28] using a properly modified procedure. In brief, 2-isocyanatoethyl methacrylate 180
(1.4 mL, 10 mmol) was added to a mixture of DHQD (1.3 g, 4 mmol), dibutyltin 181
dilaurate (10 drops) and 4-methoxyphenol (10 mg) in THF (30 mL), followed by 182
stirring for 96 h at room temperature. The mixture was filtered, concentrated under 183
reduced pressure. The residue was purified on a packed silica column using a eluent184
consisting of chloroform /MeOH (40:1; v/v) to afford MQD (white powder, yield 185
58.7%). 186
187
2.4.2. Preparation of poly(MQD-co-HEMA-co-EDMA) monolithic columns188
The monomers (MQD, HEMA, and EDMA), the binary porogenic mixture189
(1-dodecanol and cyclohexanol) and the initiator AIBN (1 wt% with respect to the 190
monomers) were mixed ultrasonically into a homogenous solution in a 2-mL vial. The 191
composition of the polymerization mixture was optimized in order to obtain 192












satisfactory permeability and selectivity (Table 1). After sonication and bubbling with 193
nitrogen for 5 min, this polymerization mixture was transferred into a 20-cm long 194
capillary, which had been pretreated with -MAPS in order to afford anchoring sites 195
for the polymeric bulk [34-35]. The filled capillaries were sealed with GC septa and 196
submerged into a water bath at 60 oC for 20 h. The obtained monolithic columns were 197
then flushed out using MeOH in order to remove unreacted chemicals and porogens. 198
A 2-3 mm detection window was created at a distance of 3 cm from the end of the 199
column using a thermal wire stripper. The capillary column was cut into a total length 200
of 18 cm with an effective length of 15 cm. The finally obtained bulk polymer was 201
taken for elemental analysis. A 3-5 mm length of monolith was then cut, placed on an 202
aluminum stub and then sputter-coated with gold for SEM analysis.203
204
2.5. Calculations205
The enantioselectivity () was calculated according to the following expression: = 206
k2/k1 where k = (tR-t0)/t0 (t0 is the elution time of the solvent peak, which was used as 207
the dead time, tR1, tR2, k1 and k2 are the retention times and the retention factors of the 208
first and second eluting enantiomers, respectively) [34]. The theoretical plate number 209
(N) and the resolution factor (Rs) were determined according to the standard equations 210
based on their corresponding widths at half-height [36].211
212
3. Results and discussion 213
3.1. Preparation and optimization of poly(MQD-co-HEMA-co-EDMA) 214
monolithic columns215
Lämmerhofer et al. previously prepared successfully a quinidine-based chiral 216
monolithic column for enantioseparations in the CEC mode [28]. However, a column 217
with satisfactory performance in CEC might not be suitable for a successful HPLC 218
separation. The permeability is a very important property of an HPLC column 219
because of its direct and indirect influence on a number of factors, such as stability, 220
analysis time, column efficiency, resolution etc. In order to obtain a poly221
(MQD-co-HEMA-co-EDMA) monolithic column with satisfactory permeability and 222
efficiency in micro-HPLC, the composition of the polymerizable mixture was 223
re-optimized as shown in Table 1 by evaluating the properties and structure of the224
monoliths using micro-HPLC and SEM. 225












In order to investigate the effect of the porogens in the reaction mixture, the weight 226
content of the binary porogenic mixture was varied from 70% (C1) to 60% w/w (C3) 227
while the composition of monomers and porogens was kept constant. It was observed 228
that the decrease of the total weight content of porogens resulted in a clear increase of 229
the backpressure from 2.9 MPa to 10.1 MPa. Column C2 exhibited a suitable230
backpressure and the highest column efficiency (24400 theoretical plates/m at a linear 231
flow rate of 1.1 mm/s using naphthalene as test compound) when compared to 232
columns C1 and C3. 233
It was also observed that the co-monomer HEMA affected the column performance. 234
As the weight fraction of HEMA in the monomers increased from 52.5% (C2) to 235
57.5% (C5) w/w, the theoretical plate number increased from 24400 to 32000 236
plates/m while the backpressure remained almost constant. A further increase of the237
HEMA weight content to 60% (C6) caused a significant increase of backpressure and238
a slight decrease in column efficiency. Therefore, considering the column239
permeability and efficiency, a HEMA weight content of 57.5% in the monomers was 240
selected for all further experiments.241
The composition of the porogenic mixture (dodecanol/cyclohexane ratio) was also 242
taken into consideration. The micro-HPLC experiments showed that the column 243
backpressure increased from 5.8 MPa to 13.1 MPa when the content of dodecanol244
decreased from 88.33% (C7) to 78.33% (C8) wt%. On the other hand, the best column 245
efficiency was obtained on column C5 with 83.33 % dodecanol in the porogenic 246
mixture. 247
Finally, a polymerization mixture consisting of 35 wt% monomers 248
(MQD/HEMA/EDMA, 20/57.5/22.5, w/w/w) and 65 wt% porogens 249
(dodecanol/cyclohexanol, 83.33/16.67, w/w) was chosen for all further studies since it250
yielded the monolith C5 exhibiting uniform structure and good permeability and 251
efficiency. Fig. 1a and Fig. 1b shows the SEM result for column C5, where spherical 252
units agglomerate into large clusters interdispersed by large-pore channels. 253
254
3.2. Permeability and reproducibility of poly(MQD-co-HEMA-co-EDMA) 255
monolithic columns256
The permeability of the poly(MQD-co-HEMA-co-EDMA) monolithic column was 257
determined by pumping ACN, MeOH, and water through it at different linear flow 258
rates. According to Bristow and Knox [37], the permeability K can be expressed as 259














whereis the dynamic viscosity of the eluent, u is the linear velocity of the mobile 262
phase, L is the length of the column, and ΔP is the pressure drop across the column. 263
Since toluene was unretained in organic mobile phases, it was selected as dead-time 264
marker when ACN and MeOH were used as eluents. When using water as mobile 265
phase, thiourea was selected as t0 marker. The good mechanical stability of column 266
C5 could be evidenced by the excellent linearity between backpressure and linear 267
velocity over the pressure range of 0-13 MPa (Figure not shown). The calculated K 268
values for column C5 are given in Table 2. The results indicate a high permeability 269
for the optimized poly(MQD-co-HEMA-co-EDMA) monolithic column, which is 270
ideal for HPLC applications.271
In addition, the reproducibility of the poly(MQD-co-HEMA-co-EDMA) monolithic 272
columns was assessed by determining the relative standard deviations (RSDs) for the 273
retention factors of two test analytes, i.e. anisole and naphthalene. A mixture of 274
ACN/H2O (40/60, v/v) was used as mobile phase. The RSD values for run to run (n = 275
10) repeatability of anisole and naphthalene retention factors were 0.88% and 1.08%, 276
respectively. The RSD values for day to day (n=5) repeatability were 2.18% and 277
2.78%, respectively. These data demonstrate the stability of the 278
poly(MQD-co-HEMA-co-EDMA) monolithic columns, since their properties do not 279
seem to change significantly either with time or with the number of injections. 280
Furthermore, the batch to batch (n=3) reproducibility values for anisole and 281
naphthalene retention factors were 4.38% and 4.47%, respectively. These results282
further confirm the good reproducibility of the optimized 283
poly(MQD-co-HEMA-co-EDMA) monolithic columns.284
285
3.3. Effects of mobile phase composition on enantioseparation286
In order to systematically evaluate the enantioselectivity of the optimized 287
poly(MQD-co-HEMA-co-EDMA) monolithic columns in the micro-HPLC mode, two 288
N-derivatized amino acids, i.e. 3,5-DNB-Leucine and 3,5-DClB-Leucine, were chosen 289
as test analytes. The influence of the organic solvent type and concentration, the 290
apparent pH and the buffer concentration was investigated.291
The influence of the organic solvent type (MeOH and ACN) in the mobile phase on 292
retention times and enantioselectivity was first studied. Both 3,5-DNB-Leucine and 293












3,5-DClB-Leucine could be enantioseparated with mixtures of either MeOH/0.1 M 294
ammonium acetate (80/20, v/v, apparent pH = 5.3) or ACN/0.1 M ammonium acetate 295
(80/20, v/v, apparent pH = 5.3) as mobile phase. However, the retention of the second 296
enantiomer of 3,5-DNB-Leucine was too high to be eluted from the column within 297
120 min when MeOH/0.1 M ammonium acetate (80/20, v/v, apparent pH = 5.3) was 298
used as mobile phase. Therefore ACN/H2O system was chosen for studying the 299
influence of the organic solvent concentration on the enantioseparation of the two300
N-derivatized amino acids. As can be seen in Table 3, the retention factors of both 301
analytes increased dramatically with decreasing ACN content from 80 to 60%.302
However the enantioselectivity () remained fairly constant over the studied ACN 303
concentration range while the enantioresolution (Rs) increased with decreasing ACN 304
concentration, owing to increasing retention and column efficiency. This might 305
suggest that part of the retention on the poly(MQD-co-HEMA-co-EDMA) monolithic 306
stationary phase under the tested conditions is due to hydrophobic interaction and that 307
the latter is not responsible for enantioselectivity. In order to find the best compromise 308
between retention times and enantioresolution, a mobile phase containing 80% ACN 309
was considered as the most suitable for further experiments. 310
It has been reported that the electrostatic interactions between the negatively charged 311
carboxylate function of N-derivatized amino acids and the positively charged tertiary 312
nitrogen of quinidine play an important role in the enantioselectivity of 313
quinidine-based stationary phases [8]. The mobile phase pH could affect the 314
ionization state of both quinidine (pKa = 8.72) [38] stationary phase and analytes, i.e. 315
3,5-DNB-Leucine (pKa = 3.77) [39] and 3,5-DClB-Leucine (pKa = 3.79) [39]. 316
Therefore its effect on the enantioseparation of the two N-derivatized amino acids was 317
also investigated by adjusting the apparent pH value of the mobile phase (ACN/0.1 M 318
ammonium acetate (80/20; v/v)) to 6.3, 5.3 and 4.3 after mixing with ACN. As shown 319
in Table 4, both retention factors (k1 and k2) and Rs of 3,5-DNB-Leucine and 320
3,5-DClB-Leucine decreased with decreasing mobile phase apparent pH from 6.3 to 321
4.3. The α values remained almost constant between pH 6.3 and 5.3, and then 322
decreased significantly at pH 4.3. This behavior is certainly related to the fact that in 323
the selected apparent pH range, the quinidine stationary phase remains fully positively 324
charged while the negative charge of the two N-derivatized amino acids will start 325
decreasing with decreasing apparent pH, resulting in a reduction of electrostatic326












interactions and hence of enantioselectivity. Finally, an apparent pH of 5.3 was 327
selected because it represented the best compromise between enantioresolution and 328
analysis time.329
The influence of the buffer concentration was also investigated by varying the 330
concentration of ammonium acetate from 0.05 to 0.15 M, while the other 331
chromatographic conditions were kept constant (Table 5). No significant influence on 332
enantioselectivity for both N-derivatized amino acids was observed in this 333
concentration range. However, their retention and enantioresolution clearly increased334
with decreasing ammonium acetate concentration. These results might indicate that 335
the contribution of electrostatic interactions to the retention of these acidic analytes336
increases with decreasing concentration of the competing anion acetate. A 0.1 M 337
concentration of ammonium acetate was found to be the most suitable with respect to 338
enantioresolution and analysis time.339
340
3.4. Enantioseparation of N-derivatized amino acids341
In order to systematically evaluate the enantioselectivity of poly 342
(MQD-co-HEMA-co-EDMA) monolithic columns in the micro-HPLC mode, various343
kinds of N-derivatized amino acids were synthesized and enantioseparated (Table 6).344
The tagging reagents used to derivatize the amino acids included the following 345
N-protecting groups: B, p-NB, 3,5-DNB, 3,5-DMB, Fmoc, 3,5-DClB, m-ClB, p-ClB 346
and o-ClB (Fig. 2). 347
The results (k1, k2, α, Rs, N1 and N2) obtained for 47 N-derivatized amino acids348
(alanine, isoleucine, leucine, methionine, valine, threonine, phenylalanine, cysteine, 349
serine, and tryptophan derivatives) on poly (MQD-co-HEMA-co-EDMA) monolithic 350
columns are given in Table 6. Under the selected chromatographic conditions, 44 out 351
of 47 analytes could be baseline enantioresolved (Rs > 1.5), and the other three 352
analytes could be partially enantioseparated (0.74 ≤ Rs < 1.5). The highest 353
enantioresolution values were observed for 3,5-DNB derivatives, followed by 354
3,5-DClB derivatives. It was also noticed that the poly (MQD-co-HEMA-co-EDMA) 355
monolithic column optimized for micro-HPLC could offer a better enantioselectivity 356
within a shorter analysis time comparing with the previously reported poly 357
(MQD-co-HEMA-co-EDMA) monolithic column used in CEC [28]. For instance, α358
value of ~ 2.91 and Rs value of ~ 8.44 for 3,5-DNB-Leucine enantiomers were359
obtained over 40 minutes in the CEC mode [28], while α value of ~ 4.71 and Rs value 360












of ~ 8.51 for 3,5-DNB-Leucine enantiomers were reached less than 12 minutes in the361
micro-HPLC mode. These results further demonstrate the great potential of the362
poly(MQD-co-HEMA-co-EDMA) monolithic column to enantioresolve a wide range363
of N-derivatized amino acids.364
When the results in Table 6 are more closely examined, a similar trend in 365
enantioselectivity for amino acid derivatives in each series was noticed. For instance, 366
α values for 3,5-DClB amino acid enantiomers were in the following rank order:367
isoleucine > valine > phenylalanine > leucine > tryptophan > methionine > threonine 368
> cysteine > alanine > serine. Lindner et. al. showed that the lipophilicity and 369
bulkiness of the side chain of the analytes may affect the enantiodiscrimination 370
potential of quinidine-based columns [8]. Furthermore, they found that an increase of371
the size and bulkiness of the side chain leads to an enhancement in the retention of the 372
second eluting enantiomer [8]. Interestingly, a similar phenomenon was observed in 373
this study. For instance, the α-values for some aliphatic amino acid enantiomers as 374
3,5-DClB derivatives increase in the order: serine (hydroxymethyl, α = 2.18) < 375
cysteine (thiomethyl, α = 2.28) < threonine (1-hydroxyethyl, α = 2.57), and alanine 376
(methyl, α = 2.21) < leucine (isobutyl, α = 3.12) < isoleucine (sec.-butyl, α = 4.24). 377
In order to study the influence of N-protecting groups on the enantioseparation, eight 378
different N-derivatized leucine derivatives were selected. As shown in Table 7 and 379
Fig. 3, baseline enantioseparation could be achieved on the poly 380
(MQD-co-HEMA-co-EDMA) column for all eight analytes. Furthermore, the 381
enantioselectivity for the amino acid derivatives decreased with decreasing 382
electrophilic character of the N-protecting groups. This trend could be deduced from 383
the reduction of enantioselectivity obtained by exchanging the strong π-acidic384
3,5-DNB groups for the weaker π-acidic p-NB and B groups: e.g. α385
(3,5-DNB-Leu ine) = 4.71 > α (p-NB-Leucine) = 1.74 > α (B-Leucine) = 1.34.386
Lindner et. al. showed that the N-protecting groups could provide a strongly 387
electron-deficient aromatic system for π-π interaction with the quinoline ring of 388
quinidine [8]. The effective π-π interaction increment of the N-protecting groups389
could improve the enantioselectivity for N-derivatized amino acids [8].390
In order to confirm the enantiomer elution order, L-form enantio-enriched  391
3,5-DNB-Methionine and 3,5-DNB-Alanine were used as analytes. As can be seen in 392
Fig. 4, the L-enantiomers were always eluted first. The same enantiomer elution order 393
has been previously observed for 3,5-DNB-Leucine [28] and Fmoc-Leucine [29], 394












which suggests that the L-enantiomers are more or less excluded from the “binding 395
groove” of the quinidine moiety whereas the D-enantiomers better match the binding 396
sites [8]. 397
398
3.4.1. Chemoselectivity of the poly (MQD-co-HEMA-co-EDMA) monolithic 399
column400
A major limitation of CSPs is often their intrinsically limited chemoselectivity. In 401
order to evaluate the chemoselectivity of poly(MQD-co-HEMA-co-EDMA)402
monolithic stationary phases, a mixture of 3,5-DClB-Leucine, 3,5-DClB-Valine, and 403
3,5-DClB-Tryptophan enantiomers was tested under isocratic conditions in404
micro-HPLC. Fig. 5 shows that all three pairs of 3,5-DClB amino acid enantiomers405
could be completely separated in less than 22.5 minutes. Hence, the poly 406
(MQD-co-HEMA-co-EDMA) monolithic column can be used for the 407
enantioseparation of a multicomponent mixture of N-derivatized amino acids in the 408
micro-HPLC mode.     409
410
4. Conclusion411
In this research, a capillary monolithic column containing carbamoylated quinidine as 412
chiral selector was re-optimized in order to obtain satisfactory column permeability, 413
efficiency and selectivity in micro-HPLC. The optimized poly 414
(MQD-co-HEMA-co-EDMA) monolithic column showed excellent morphology, 415
good permeability, reproducibility, mechanical and chemical stability and satisfactory 416
chromatographic performance in micro-HPLC. The influence of the organic solvent 417
content, the buffer concentration and the apparent pH of the mobile phase on the418
retention and enantioseparation of N-derivatized amino acids seems to confirm that 419
both hydrophobic and electrostatic interactions are responsible for the retention of 420
these acidic analytes, while only the latter contribute to enantioselectivity. Based on a 421
comparison of the influence of the type of N-protecting groups and amino acids on 422
enantioseparation, it was deduced that the size and bulkiness of the side chain of 423
amino acids as well as the electrophilic character of the N-protecting groups are likely 424
to affect the enantiodiscrimination potential of the poly(MQD-co-HEMA-co-EDMA) 425












monolithic column. The optimized monolithic column was finally applied to the 426
enantioseparation of a wide range of N-derivatized amino acids with exceptionally 427
high selectivity values and good resolution, especially for 3,5-DNB-amino acids and 428
3,5-DClB-amino acids. Good chemoselectivity of the monolithic column for a 429
multicomponent mixture of N-derivatized amino acids was also observed.430
431
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Fig. 1. Scanning electron microphotographs of column C5.495
496
Fig. 2. Structures of amino acids and N-protecting groups.497
498
Fig. 3. Enantioseparation of N-derivatized leucine derivatives on the499
poly(MQD-co-HEMA-co-EDMA) monolithic column. Conditions: column 500
dimensions: 150 mm × 100 µm I.D.; mobile phase: a). ACN/0.1 M ammonium acetate501
(80/20, v/v) (apparent pH = 5.3) for all analytes except Fmoc-Leucine, b). ACN/0.1 M 502
ammonium acetate (50/50, v/v) (apparent pH = 5.3) for Fmoc-Leucine; UV detection 503
wavelength: 254 nm; flow rate: 1 μL/min; injection volume: 20 nL.504
505
Fig. 4. Elution order of 3,5-DNB-Methionine  and 3,5-DNB-Alanine506
enantiomers on the poly(MQD-co-HEMA-co-EDMA) monolithic column. 507
Conditions: mobile phase, ACN/0.1 M ammonium acetate (80/20, v/v) (apparent pH = 508
5.3); other conditions as in Fig. 3.509
510
Fig. 5. Enantioseparation of 3,5-DClB-Leucine, 3,5-DClB-Valine  and511
3,5-DClB-Tryptophan. Conditions: flow rate: 0.5 μL/min; samples:512
3,5-DClB-Leucine (1, 4), 3,5-DClB-Valine (2, 5) and 3,5-DClB-Tryptophan (3, 6); 513
other conditions as in Fig. 4. 514
515
Table 1. Composition of the polymerization mixtures used for the preparation of 516
poly(MQD-co-HEMA-co-EDMA) monolithic columns and their properties.517
Conditions: column dimensions: 150 mm × 100 µm I.D.; mobile phase, ACN/H2O 518
(40/60, v/v); UV detection wavelength: 214 nm; flow rate: 1 μL/min; injection519
volume: 20 nL; sample: naphthalene.520
521
522
Table 2. Permeability of the poly(MQD-co-HEMA-co-EDMA) monolithic column523












a Relative polarity data were obtained from 524
http://virtual.yosemite.cc.ca.us/smurov/orgsoltab.htm; viscosity data of pure solvents 525
were obtained from reference [32].526
527
Table 3. Effect of ACN content in the mobile phase on the retention and528
enantioseparation of N-derivatized amino acids. Conditions: column: 150 mm × 529
100 µm I.D. poly(MQD-co-HEMA-co-EDMA); mobile phase: mixture of ACN and 530
0.1 M ammonium acetate at various ratios (apparent pH = 5.3); UV detection 531
wavelength: 254 nm; flow rate: 1 μL/min; injection volume: 20 nL.532
533
534
Table 4. Effect of the mobile phase apparent pH on the retention and535
enantioseparation of N-derivatized amino acids. Conditions: mobile phase, 536
ACN/0.1 M ammonium acetate (80/20, v/v) adjusted to different apparent pH values;537




Table 5. Effect of the buffer concentration on the retention and542
enantioseparation of N-derivatized amino acids. Conditions: ACN/different543
concentrations of ammonium acetate (80/20, v/v) (apparent pH = 5.3); other 544




Table 6. Enantioseparation of N-derivatized amino acids. Conditions: mobile 549
phase, aACN/0.1 M ammonium acetate solution (80/20, v/v) (apparent pH = 5.3); b550
ACN/0.1 M ammonium acetate (50/50, v/v) (apparent pH = 5.3); c ACN/ 0.1 M 551
ammonium acetate (40/60, v/v) (apparent pH = 5.3); other conditions as in Fig. 3; “/”:552
the number of theoretical plates cannot be calculated.553
554
Table 7. Comparison of retention factors, selectivity and enantioresolution for555
different N-derivatized leucine derivatives. Conditions as in Fig. 3.556













 A carbamoylated quinidine based monolith was prepared for using in 595
micro-HPLC.596
 This monolithic column exhibited great properties for chromatographic 597
performance in micro-HPLC .598

















































































































































































































































































































































































Table 1. Composition of the polymerization mixtures used for the preparation of poly(MQD-co-HEMA-co-EDMA) monolithic columns 
and their properties.  
 
Column 
Monomers (%, w/w) 
Porogens 
(%,w/w) 
Monomers : Porogens 
(%, w/w) 
Back-pressure (MPa) Theoretical plates (m-1) 
MQD HEMA EDMA Dodecanol Cyclohexanol 
  
C1 20 52.5 27.5 83.33 16.67 30 70 2.9 20600 
C2 20 52.5 27.5 83.33 16.67 35 65 5.4 24400 
C3 20 52.5 27.5 83.33 16.67 40 60 10.1 21000 
C4 20 55 25 83.33 16.67 35 65 5.6 26500 
C5 20 57.5 22.5 83.33 16.67 35 65 6.2 32000 
C6 20 60.0 20.0 83.33 16.67 35 65 19.2 26200 
C7 20 57.5 22.5 88.33 11.67 35 65 5.8 20500 
C8 20 57.5 22.5 78.33 21.67 35 65 13.1 20700 
Conditions: column dimensions: 150 mm × 100 µm I.D.; mobile phase, ACN/H2O (40/60, v/v); UV detection wavelength: 214 nm; flow rate: 1 μL/min; injection 
volume: 20 nL; sample: naphthalene. 
Table-1


















 (×10-3 Pa·s)[32] 
Permeability  
K (×10-13 m2) 
ACN 0.460 0.369 1.547 
MeOH 0.762 0.544 1.024 
Water 1 0.890 0.839 
a
 Relative polarity data were obtained from http://virtual.yosemite.cc.ca.us/smurov/orgsoltab.htm; 
viscosity data of pure solvents were obtained from reference [32]. 
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Table 3. Effect of ACN content in the mobile phase on the retention and enantioseparation of N-derivatized amino acids. 
 
 80% 70% 60% 
 k1 k2 α Rs N1/m N2/m k1 k2 α Rs N1/m N2/m k1 k2 α Rs N1/m N2/m 
3,5-DNB-Leucine 1.00 4.71 4.71 8.51 16600 8600 1.71 7.70 4.52 9.60 15400 9662 2.56 11.97 4.67 11.40 19400 11700 
3,5-DClB-Leucine 1.01 3.15 3.12 6.64 16100 10200 1.88 5.67 3.03 8.04 15100 12377 2.94 9.16 3.11 9.69 20200 14100 
Conditions: column: 150 mm × 100 µm I.D. poly(MQD-co-HEMA-co-EDMA); mobile phase: mixture of ACN and 0.1 M ammonium acetate at various ratios 
(apparent pH = 5.3); UV detection wavelength: 254 nm; flow rate: 1 μL/min; injection volume: 20 nL. 
Table-3











Table 7. Comparison of retention factor, selectivity and enantioresolution of 
different N-derivatized leucine derivatives. 
 
Analyte k1 k2 α Rs 
3,5-DNB-Leucine 1.00  4.71  4.71  8.51 
3,5-DClB-Leucine 1.01  3.15  3.12  6.64  
3,5-DMB-Leucine 2.35  5.31  2.26  5.30  
m-ClB-Leucine 3.35  6.42  1.92  4.94  
p-NB-Leucine 2.18  3.80  1.74  3.68  
p-ClB-Leucine 2.11  3.51  1.66  3.34  
B-Leucine 2.89  3.87  1.34  2.31  
Fmoc-Leucine 6.66  8.27  1.24  1.53  
Conditions as in Fig. 3. 
Table-7











Table 4. Effect of the mobile phase apparent pH on the retention and enantioseparation of N-derivatized amino acids. 
 
 pH 6.3 pH 5.3 pH 4.3 
 k1 k2 α Rs N1/m N2/m k1 k2 α Rs N1/m N2/m k1 k2 α Rs N1/m N2/m 
3,5-DNB-Leucine 2.26  10.55  4.68  10.52  14600  10600  1.00  4.71  4.71  8.51  16600  8600  0.48  1.91  3.96  4.36  7200  5200  
3,5-DClB-Leucine 4.60  14.22  3.09  8.80  12200  11500  1.01  3.15  3.12  6.64  16100  10200  0.49  1.25  2.55  3.01  8100  6400  
Conditions: mobile phase, ACN/0.1 M ammonium acetate (80/20, v/v) adjusted to different apparent pH values; other conditions as in Table 3. 
Table-4











Table 5. Effect of the buffer concentration on the retention and enantioseparation of N-derivatized amino acids. 
 
 0.15 M 0.10 M 0.05 M 
 k1 k2 α Rs N1/m N2/m k1 k2 α Rs N1/m N2/m k1 k2 α Rs N1/m N2/m 
3,5-DNB-Leucine 0.77 3.63 4.70 7.75 13600 8600 1.00 4.71 4.71 8.51 16600 8600 1.71 7.88 4.61 10.38 15000 11500 
3,5-DClB-Leucine 0.73 2.36 3.22 6.05 14000 10500 1.01 3.15 3.12 6.64 16100 10200 1.70 5.40 3.18 7.94 17900 10600 
Conditions: ACN/different concentrations of ammonium acetate (80/20, v/v) (apparent pH = 5.3); other conditions as in Table 3. 
Table-5











Table 6. Enantioseparation of N-derivatized amino acids. 
 
Sapmle k1 k2 α Rs N1/m N2/m 
3,5-DNB-Isoleucinea 2.56 17.88 6.98 8.74 4500 4200 
3,5-DNB-Valinea 2.93 16.26 5.55 8.92 7400 5000 
3,5-DNB-Tryptophana 4.43 22.00 4.97 7.32 4400 3600 
3,5-DNB-Leucinea 1.00 4.71 4.71 8.51 16600 8600 
3,5-DNB-Phenyalaninea 3.27 15.21 4.65 9.95 4900 4200 
3,5-DNB-Methioninea 3.05 13.24 4.33 8.09 8400 5100 
3,5-DNB-Threoninea 3.86 14.07 3.64 8.14 6000 6700 
3,5-DNB-Cysteinea 5.68 19.88 3.50 4.31 2000 1900 
3,5-DNB-Alaninea 3.55 11.30 3.19 8.06 10700 7400 
3,5-DNB-Serinea 4.52 14.05 3.11 8.47 10500 8400 
3,5-DClB-Isoleucinea 1.31 5.58 4.24 8.71 17100 9200 
3,5-DClB-Valinea 1.39 4.76 3.42 8.74 19200 12800 
3,5-DClB-Phenyalaninea 2.29 7.65 3.33 8.17 15400 9400 
3,5-DClB-Leucinea 1.01 3.15 3.12 6.64 16100 10200 
3,5-DClB-Tryptophana 2.33 7.13 3.06 6.87 10400 8000 
3,5-DClB-Methioninea 1.39 4.10 2.95 7.33 13300 13100 
3,5-DClB-Threoninea 2.15 5.52 2.57 8.00 21000 15400 
3,5-DClB-Cysteninea 3.41 7.78 2.28 5.22 14000 6300 
3,5-DClB-Alaninea 1.94 4.30 2.21 6.79 22100 16300 
3,5-DClB-Serinea 2.70 5.88 2.18 7.55 23800 18800 
Fmoc-Isoleucineb 9.58 13.50 1.41 2.90 9700 8800 
Fmoc-Valineb 8.20 11.47 1.40 2.76 9100 8600 
Table-6











Fmoc-Phenylalanineb 9.33 11.82 1.27 1.84 7800 7600 
Fmoc-Cysteinec 13.91 17.61 1.27 1.58 5500 5400 
Fmoc-Tryprophanb 12.18 15.33 1.26 1.69 7100 6300 
Fmoc-Leucineb 6.66 8.27 1.24 1.53 6900 6900 
Fmoc-Serineb 4.43 5.47 1.23 1.56 9100 8300 
Fmoc-Methionineb 5.82 7.08 1.22 1.43 7700 7500 
Fmoc-Alaninec 8.40 9.77 1.16 1.38 10100 9900 
3,5-DMB-Leucinea 2.35 5.31 2.26 5.30 8300 7800 
3,5-DMB-Methioninea 2.12 4.20 1.98 4.50 9500 8100 
3,5-DMB-Alaninea 2.06 3.53 1.71 3.98 12700 10300 
p-NB-Leucinea 2.18 3.80 1.74 3.68 9400 8300 
p-NB-Methioninea 2.74 4.43 1.62 3.75 11500 10500 
p-NB-Threoninea 3.93 5.87 1.49 3.91 15500 14700 
p-NB-Alaninea 2.69 3.84 1.43 3.08 14100 13800 
m-ClB-Leucinea 3.35 6.42 1.92 4.94 11000 8800 
m-ClB-Threoninea 3.44 5.72 1.67 4.43 12600 12600 
m-ClB-Alaninea 3.08 4.67 1.52 3.72 14200 13400 
m-ClB-Methioninea 2.83 3.70 1.31 2.22 12800 12400 
p-ClB-Leucinea 2.11 3.51 1.66 3.34 9400 8400 
p-ClB-Methioninea 3.03 4.62 1.52 3.53 12600 11900 
p-ClB-Alaninea 2.95 4.02 1.36 2.87 16100 14700 
B-Leucinea 2.89 3.87 1.34 2.31 11800 10900 
B-Methioninea 2.81 3.67 1.31 2.17 12500 11700 
B-Threoninea 4.25 5.32 1.25 2.27 16400 15500 











o-ClB-Methioninea 5.83 6.30 1.08 0.74 / / 
Conditions: mobile phase, 
a
ACN/0.1 M ammonium acetate solution (80/20, v/v) (apparent pH = 
5.3); 
b
 ACN/0.1 M ammonium acetate (50/50, v/v) (apparent pH = 5.3); 
c
 ACN/ 0.1 M ammonium 
acetate (40/60, v/v) (apparent pH = 5.3); other conditions as in Fig. 3; “/”: the number of 
theoretical plates cannot be calculated. 
